Sample PReanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols

: The suitability of samples for a given research depends on many variables, among which, the best preanalytical conditions for the type of test that should be carried out. Thus, standardization and harmonization of processing conditions for samples entering a particular study should be highly pursued to facilitate research collaborations among different institutions and biological banks, allowing specimen comparison both for sample sharing and for the development of large-scale clinical trials. In this study, we review some issues and scenarios related to the adoption of the Sample PREanalytical Code, which deserve attention for a proper management of the samples and, ultimately, for maximizing the efficiency of the consistent investments required to set up biobanking resources.

[1]  Helen M. Moore,et al.  A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen? , 2014, Archives of pathology & laboratory medicine.

[2]  G. Davı̀,et al.  Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy , 2014, Haematologica.

[3]  Leyla Demir,et al.  Clinical biochemistry laboratory rejection rates due to various types of preanalytical errors , 2014, Biochemia medica.

[4]  V. Neumeister.  Tools to assess tissue quality. , 2014, Clinical biochemistry.

[5]  Erica E Benson,et al.  Is there a protocol for using the SPREC? , 2013, Biopreservation and biobanking.

[6]  Vicki A. Funk,et al.  Utility of QR codes in biological collections , 2013, PhytoKeys.

[7]  Helen M. Moore,et al.  Biospecimen Reporting for Improved Study Quality (BRISQ) , 2013, Transfusion.

[8]  B. Han,et al.  Identification of clinical biomarkers for pre-analytical quality control of blood samples. , 2013, Biopreservation and biobanking.

[9]  A. Dirican,et al.  The effect of storage time and freeze-thaw cycles on the stability of serum samples , 2013, Biochemia medica.

[10]  P. Gasparini,et al.  Age- And Sex-Related Variations in Platelet Count in Italy: A Proposal of Reference Ranges Based on 40987 Subjects' Data , 2013, PloS one.

[11]  C. Beyan.  Is Mean Platelet Volume a Predictive Marker in Patients With Venous Thrombosis? , 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[12]  Umberto Nanni,et al.  Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). , 2012, Biopreservation and biobanking.

[13]  Umberto Nanni,et al.  SPRECware: Software Tools for Standard PREanalytical Code (SPREC) Labeling – Effective Exchange and Search of Stored Biospecimens , 2012, The International journal of biological markers.

[14]  Katherine C Sexton,et al.  Development of the ISBER Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. , 2012, Biopreservation and biobanking.

[15]  Erica E Benson,et al.  Standard PREanalytical Codes: A New Paradigm for Environmental Biobanking Sectors Explored in Algal Culture Collections. , 2011, Biopreservation and biobanking.

[16]  Fotini Betsou,et al.  Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks , 2011, Journal of biomolecular NMR.

[17]  F. Guadagni,et al.  RFID as a New ICT Tool to Monitor Specimen Life Cycle and Quality Control in a Biobank , 2011, The International journal of biological markers.

[18]  Clive R. Taylor,et al.  Focus on biospecimens: the issue is the tissue. observations on the "NCI-NIST fitness-for-purpose quality assessment and standards development workshop," October 2010. , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[19]  F. Guadagni,et al.  Platelet activation and vascular endothelial growth factor 165 release in hepatocellular cancer. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[20]  Stephen M Hewitt,et al.  Factors Influencing the Degradation of Archival Formalin-Fixed Paraffin-Embedded Tissue Sections , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  Steven S. Silver,et al.  Considerations for uniform and accurate biospecimen labelling in a biorepository and research environment , 2011, Journal of Clinical Pathology.

[22]  A. Hillarp,et al.  Considerations in the laboratory assessment of haemostasis , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  F. Guadagni,et al.  Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions. , 2010, Clinical biochemistry.

[24]  F. Betsou,et al.  Standard Preanalytical Coding for Biospecimens: Defining the Sample PREanalytical Code , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[25]  Helen M. Moore,et al.  2009 Biospecimen research network symposium: advancing cancer research through biospecimen science. , 2009, Cancer research.

[26]  L. Uhl,et al.  Strict adherence to a blood bank specimen labeling policy by all clinical laboratories significantly reduces the incidence of "wrong blood in tube". , 2009, American journal of clinical pathology.

[27]  Thomas Burke,et al.  Human Biospecimen Research: Experimental Protocol and Quality Control Tools , 2009, Cancer Epidemiology Biomarkers & Prevention.

[28]  H. Katus,et al.  Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation. , 2007, Clinical chemistry.

[29]  Peter J Pronovost,et al.  Surgical specimen identification errors: a new measure of quality in surgical care. , 2007, Surgery.

[30]  S. Kitchen,et al.  Emerging technologies and quality assurance: the United Kingdom National External Quality Assessment Scheme perspective. , 2007, Seminars in thrombosis and hemostasis.

[31]  P. Libby,et al.  Influence of pre-analytical and analytical factors on soluble CD40L measurements. , 2006, Clinical science.

[32]  for the Statistics Subcommittee of the NCI—EORTC Worki Diagnostics.  REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2005, Nature Clinical Practice Oncology.

[33]  A. Tripodi.  A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia. , 2005, Seminars in thrombosis and hemostasis.

[34]  S. Kitchen,et al.  Multilaboratory Testing in Thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program , 2005, Seminars in thrombosis and hemostasis.

[35]  S. Bonini,et al.  Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study , 2000, BMJ : British Medical Journal.

[36]  A. Kahng,et al.  International , 1964, PS: Political Science & Politics.

[37]  F. Betsou.  Biospecimen processing method validation. , 2015, Biopreservation and biobanking.

[38]  Council of Europe.  Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research , 2005 .